These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 38808995)

  • 21. Shingles update: common questions in caring for a patient with shingles.
    Madison LK
    Dermatol Nurs; 2001 Feb; 13(1):51, 54-5. PubMed ID: 11917300
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Time-varying association between herpes zoster infection and subsequent occurrence of stroke.
    Lapi F; Marconi E; Concia E; Parretti D; Murrone A; Rossi A; Perno CF; Cricelli C
    Public Health; 2024 Apr; 229():80-83. PubMed ID: 38412697
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessing the effectiveness of zoster vaccine live: A retrospective cohort study using primary care data in the United Kingdom.
    Matthews I; Lu X; Dawson H; Bricout H; O'Hanlon H; Yu E; Nozad B
    Vaccine; 2018 Nov; 36(46):7105-7111. PubMed ID: 30195489
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Family history and herpes zoster risk in the era of shingles vaccination.
    Hernandez PO; Javed S; Mendoza N; Lapolla W; Hicks LD; Tyring SK
    J Clin Virol; 2011 Dec; 52(4):344-8. PubMed ID: 21924676
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognosis of herpes zoster in healthy children.
    Wurzel CL; Kahan J; Heitler M; Rubin LG
    Am J Dis Child; 1986 May; 140(5):477-8. PubMed ID: 3962944
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Why should older adults receive the shingles vaccine?
    Harkness TL
    J Gerontol Nurs; 2010 Oct; 36(10):51-5. PubMed ID: 20506935
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antiviral therapy for varicella and herpes zoster.
    Arvin AM
    Semin Pediatr Infect Dis; 2002 Jan; 13(1):12-21. PubMed ID: 12118839
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Herpes zoster and varicella in children with Hodgkin's disease.
    Skovby F; Sullivan MP
    Acta Paediatr Scand; 1982 Mar; 71(2):269-73. PubMed ID: 7136635
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The epidemiology of varicella and herpes zoster in The Netherlands: implications for varicella zoster virus vaccination.
    de Melker H; Berbers G; Hahné S; Rümke H; van den Hof S; de Wit A; Boot H
    Vaccine; 2006 May; 24(18):3946-52. PubMed ID: 16564115
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vaccination to prevent varicella and shingles.
    Katona SJ
    J Clin Pathol; 2002 May; 55(5):399; author reply 399. PubMed ID: 11986353
    [No Abstract]   [Full Text] [Related]  

  • 31. Severe brachial plexopathy secondary to shingles (herpes zoster).
    McFeely A; Doyle R; O'Riordan S; Connolly S; O'Dwyer C
    Age Ageing; 2021 May; 50(3):1001-1003. PubMed ID: 33765117
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunocompetent children account for the majority of complications in childhood herpes zoster.
    Grote V; von Kries R; Rosenfeld E; Belohradsky BH; Liese J
    J Infect Dis; 2007 Nov; 196(10):1455-8. PubMed ID: 18008223
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Shingles (herpes zoster) vaccine (zostavax(®)): a review of its use in the prevention of herpes zoster and postherpetic neuralgia in adults aged ≥50 years.
    Keating GM
    Drugs; 2013 Jul; 73(11):1227-44. PubMed ID: 23839657
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A systematic literature review of the epidemiology and burden of herpes zoster in selected locales in Asia Pacific.
    Chen J; Abrahamson PE; Ke Y; Ong CR; Parikh R; Shantakumar S
    Hum Vaccin Immunother; 2024 Dec; 20(1):2344983. PubMed ID: 38767209
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The cost-effectiveness of varicella and combined varicella and herpes zoster vaccination programmes in the United Kingdom.
    van Hoek AJ; Melegaro A; Gay N; Bilcke J; Edmunds WJ
    Vaccine; 2012 Feb; 30(6):1225-34. PubMed ID: 22119592
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vaccination to prevent varicella: Goldman and King's response to Myers' interpretation of Varicella Active Surveillance Project data.
    Goldman GS; King PG
    Hum Exp Toxicol; 2014 Aug; 33(8):886-93. PubMed ID: 24275643
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identifying optimal vaccination scenarios to reduce varicella zoster virus transmission and reactivation.
    Bakker KM; Eisenberg MC; Woods RJ; Martinez ME
    BMC Med; 2022 Oct; 20(1):387. PubMed ID: 36209074
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Breadth and Functionality of Varicella-Zoster Virus Glycoprotein-Specific Antibodies Identified after Zostavax Vaccination in Humans.
    Sullivan NL; Reuter-Monslow MA; Sei J; Durr E; Davis CW; Chang C; McCausland M; Wieland A; Krah D; Rouphael N; Mehta AK; Mulligan MJ; Pulendran B; Ahmed R; Vora KA
    J Virol; 2018 Jul; 92(14):. PubMed ID: 29743372
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical-epidemiological trends of herpes zoster: a 5-year study.
    Brănişteanu DE; Stoleriu G; Oanţă A; Dorobăţ CM; Petrariu FD; Anchidin DM; Ciubotaru FM; Brănişteanu DC
    Rev Med Chir Soc Med Nat Iasi; 2014; 118(3):817-22. PubMed ID: 25341306
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gender difference in the incidence of shingles.
    Fleming DM; Cross KW; Cobb WA; Chapman RS
    Epidemiol Infect; 2004 Jan; 132(1):1-5. PubMed ID: 14979582
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.